What's new

EMEA-002559-PIP09-23

EMEA-002559-PIP09-23

Mar 14, 2025 - 13:55
 0
EMEA-002559-PIP09-23
EMEA-002559-PIP09-23
Read More

Tags:

Previous Article

Fierce Pharma Asia—Takeda's oncology focus; Sun's Checkpoint buy; Ono-Ionis anti...

Next Article

Sibanye-Stillwater confirms loss of life at Driefontein

Related Posts

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 11, 2025  0

Data Analysis and Real World Interrogation Network (DARWIN EU)

Data Analysis and Real World Interrogation Network (DAR...

Feb 20, 2025  0

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0